Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1945 1
1948 1
1950 1
1951 1
1955 5
1956 6
1957 1
1958 4
1959 5
1960 2
1961 2
1962 4
1963 1
1965 4
1967 1
1968 1
1969 1
1970 2
1971 2
1972 2
1973 1
1974 3
1975 3
1978 6
1979 5
1980 4
1981 6
1982 5
1983 4
1984 5
1985 2
1986 5
1987 4
1988 9
1989 15
1990 10
1991 19
1992 20
1993 22
1994 16
1995 17
1996 21
1997 12
1998 21
1999 15
2000 24
2001 32
2002 36
2003 27
2004 27
2005 30
2006 29
2007 28
2008 27
2009 27
2010 29
2011 43
2012 36
2013 39
2014 36
2015 46
2016 49
2017 59
2018 70
2019 61
2020 79
2021 72
2022 61
2023 52
2024 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,240 results

Results by year

Filters applied: . Clear all
Page 1
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. King TE Jr, et al. Among authors: hopkins pm. N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Free article. Clinical Trial.
Biomarker signatures for progressive idiopathic pulmonary fibrosis.
Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Clynick B, et al. Among authors: hopkins pma. Eur Respir J. 2022 Mar 31;59(3):2101181. doi: 10.1183/13993003.01181-2021. Print 2022 Mar. Eur Respir J. 2022. PMID: 34675050 Free article.
Response.
McNelly AS, Bear DE, Connolly BA, Arbane G, Allum L, Tarbhai A, Cooper JA, Hopkins PA, Wise MP, Brealey D, Rooney K, Cupitt J, Carr B, Koelfat K, Olde Damink S, Atherton PJ, Hart N, Montgomery HE, Puthucheary ZA. McNelly AS, et al. Among authors: hopkins pa. Chest. 2020 Dec;158(6):2708-2711. doi: 10.1016/j.chest.2020.08.001. Chest. 2020. PMID: 33280764 No abstract available.
Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations.
Garvey LH, Dewachter P, Hepner DL, Mertes PM, Voltolini S, Clarke R, Cooke P, Garcez T, Guttormsen AB, Ebo DG, Hopkins PM, Khan DA, Kopac P, Krøigaard M, Laguna JJ, Marshall S, Platt P, Rose M, Sabato V, Sadleir P, Savic L, Savic S, Scherer K, Takazawa T, Volcheck GW, Kolawole H. Garvey LH, et al. Among authors: hopkins pm. Br J Anaesth. 2019 Jul;123(1):e50-e64. doi: 10.1016/j.bja.2019.04.044. Epub 2019 May 24. Br J Anaesth. 2019. PMID: 31130272 Free article.
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
West A, Chaudhuri N, Barczyk A, Wilsher ML, Hopkins P, Glaspole I, Corte TJ, Šterclová M, Veale A, Jassem E, Wijsenbeek MS, Grainge C, Piotrowski W, Raghu G, Shaffer ML, Nair D, Freeman L, Otto K, Montgomery AB. West A, et al. Among authors: hopkins p. Thorax. 2023 Sep;78(9):882-889. doi: 10.1136/thorax-2022-219391. Epub 2023 Mar 22. Thorax. 2023. PMID: 36948586 Free article. Clinical Trial.
Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility.
Johnston JJ, Dirksen RT, Girard T, Gonsalves SG, Hopkins PM, Riazi S, Saddic LA, Sambuughin N, Saxena R, Stowell K, Weber J, Rosenberg H, Biesecker LG. Johnston JJ, et al. Among authors: hopkins pm. Genet Med. 2021 Jul;23(7):1288-1295. doi: 10.1038/s41436-021-01125-w. Epub 2021 Mar 25. Genet Med. 2021. PMID: 33767344 Free PMC article.
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography.
Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Walsh SLF, et al. Among authors: hopkins pma. Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC. Am J Respir Crit Care Med. 2022. PMID: 35696341
What is malignant hyperthermia susceptibility?
Hopkins PM. Hopkins PM. Br J Anaesth. 2023 Jul;131(1):5-8. doi: 10.1016/j.bja.2023.04.014. Epub 2023 May 15. Br J Anaesth. 2023. PMID: 37198032 Free article.
Plasma-induced surface cooling.
Tomko JA, Johnson MJ, Boris DR, Petrova TB, Walton SG, Hopkins PE. Tomko JA, et al. Among authors: hopkins pe. Nat Commun. 2022 May 12;13(1):2623. doi: 10.1038/s41467-022-30170-5. Nat Commun. 2022. PMID: 35551424 Free PMC article.
1,240 results